Medicare Enrolled

Jena Lalley, FNP

Nurse Practitioner - Family · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
8723 BOTTS LANE, San Antonio, TX 78217
2109995523
Registered in NPPES since 2020
NPI: 1083241129 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Lalley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Lalley? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Lalley

Jena Lalley is a nurse practitioner - family in San Antonio, TX, with 6 years of NPI registration. Based on federal Medicare data, Lalley performed 91,988 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Lalley received a total of $1,634 from 24 pharmaceutical and/or device companies across 67 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Lalley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration ▲ Top 0% volume in TX $1,634 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
91,988
Medicare services
Top 0% in TX for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Romosozumab injection (Evenity) for osteoporosis 28,770 $8 $31
Denosumab injection (Prolia/Xgeva) 24,180 $19 $89
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
14,500 $0 $2
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
12,750 $1 $5
Omalizumab injection (Xolair) for asthma/allergy 5,010 $31 $135
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,828 $23 $379
Injection, benralizumab, 1 mg 1,380 $119 $531
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
675 $47 $300
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
359 $40 $250
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
297 $9 $50
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
229 $13 $125
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
225 $6 $252
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
185 $83 $500
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
175 $59 $135
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
122 $71 $245
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
109 $18 $125
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
95 $4 $43
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
71 $10 $125
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
28 $1,821 $8,123
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
17.8% high complexity
81.9% medium
0.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,634
Total received (2021-2024)
Avg $409/year across 4 years
Top 19% in TX for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
67
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$609
2023
$536
2022
$239
2021
$249

Payments by company (2024)

ABBVIE INC.
$94
Daiichi Sankyo Inc.
$76
Pharmacosmos Therapeutics Inc.
$74
AstraZeneca Pharmaceuticals LP
$63
GlaxoSmithKline, LLC.
$56
Lilly USA, LLC
$46
ADMA BioManufacturing LLC
$36
Merck Sharp & Dohme LLC
$35
Grifols USA, LLC
$28
Eisai Inc.
$24
Janssen Biotech, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Lundbeck LLC
$20
Teva Pharmaceuticals USA, Inc.
$16
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$182
GlaxoSmithKline, LLC.
$167
Genentech USA, Inc.
$142
ABBVIE INC.
$141
SI-BONE, Inc.
$139
Takeda Pharmaceuticals U.S.A., Inc.
$103
Daiichi Sankyo Inc.
$98
Pharmacosmos Therapeutics Inc.
$97
Regeneron Healthcare Solutions, Inc.
$79
Janssen Biotech, Inc.
$60
kaleo, Inc.
$53
Grifols USA, LLC
$47
Lilly USA, LLC
$46
Eisai Inc.
$44
Amgen Inc.
$41
ADMA BioManufacturing LLC
$36
Merck Sharp & Dohme LLC
$35
Horizon Therapeutics plc
$24
TerSera Therapeutics LLC
$21
Lundbeck LLC
$20
TG THERAPEUTICS, INC.
$17
Teva Pharmaceuticals USA, Inc.
$16
Merck Sharp & Dohme Corporation
$13
AIMMUNE THERAPEUTICS, INC.
$12
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
AUVI-Q · AVYCAZ · BENLYSTA · BRIUMVI · CUVITRU · DALVANCE · DUPIXENT · FASENRA · GAMMAGARD · GLASSIA · Gamunex-C · HYQVIA · INJECTAFER · KISUNLA · Leqembi · MONOFERRIC · NUCALA · OMVOH · Ocrevus · PALFORZIA · Quzyttir · SAPHNELO · SIMLANDI · STELARA · TEPEZZA · TEZSPIRE · TREMFYA · VYEPTI · Xembify · Xolair · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in San Antonio?
Compare family nurse practitioners in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
1,603
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
BAPTIST NEIGHBORHOOD HOSPITAL THOUSAND OAKS
4.8 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Lalley is a mixed practice specialist, with above-average Medicare volume (top 0% in TX).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Lalley experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Lalley performed 28,770 romosozumab injection (evenity) for osteoporosis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Lalley receive payments from pharmaceutical companies?
Yes. Lalley received a total of $1,634 from 24 companies across 67 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Lalley's costs compare to other family nurse practitioners in San Antonio?
Lalley's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Lalley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →